![](https://investorshub.advfn.com/uicon/698940.png?cb=1612432075)
Monday, April 27, 2020 10:40:07 AM
Vystar Corporation
@VystarCompany
Pricing for RX3000 has an MSRP of $7,995. This has an FDA Class II rating and kills Germs, Viruses & Bacteria also eliminates all particulates for areas like surgical suites. We can make about 25 a week currently & think we can ramp near term to 50-100 based on demand. $VYST
Make sure your buying the correct symbol if you are investing the RxAir product. VYST bought everything from UvFlu.
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM